Skip to main content
Clinical Trials/CTRI/2023/11/060084
CTRI/2023/11/060084Not yet recruitingPhase 1

Comparison of endtidal sevoflurane concentration required for optimal depth of anaesthesia during opioid free general anesthesia using intravenous lignocaine versus standard care. - nil

AMRITA INSTITUTE OF MEDICAL SCIENCES0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists physical status (ASA PS) 2 to 3,
  • Carcinoma tongue and alveolus undergoing tumor resection surgeries requiring nasal intubation

Exclusion Criteria

  • i.Patients with basal HR <60/min,
  • ii.on beta blockers,
  • iii.having cardiac arrhythmias, heart blocks, congestive heart failure,
  • iv.liver disorders with aspartate aminotransferase /alanine transaminase >2-3 times normal
  • v.renal diseases with estimated glomerular filtration rate <60ml/min/1.73m2
  • vi.hypersensitivity to lignocaine
  • vii.awake fiberoptic bronchoscope assisted intubation,
  • viii.carcinoma maxilla, craniofacial resection, exenteration, scalp, mastoid and surgeries requiring neuro assistance
  • ix.supplemental regional anaesthesia.

Investigators

Similar Trials